CXCR4 in epidermal keratinocytes: Crosstalk within the skin

Journal of Investigative Dermatology

Volumn 133, Issue 11, 2013, Pages 2505-2508

  Bollag, Wendy B ^a,b   Hill, William D ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CYTOKERATIN 14; INTERLEUKIN 23; STROMAL CELL DERIVED FACTOR 1;

ANGIOGENESIS; ARTICLE; BASAL CELL CARCINOMA; CELL PROLIFERATION; CELL TYPE; DOWN REGULATION; HUMAN; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; SKIN; SYSTEMIC LUPUS ERYTHEMATOSUS; WOUND HEALING;

EID: 84886889790     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2013.271     Document Type: Note

References (19)

1. Avniel S, Arik Z, Maly A et al. (2006) Involvement of the CXCL12/CXCR4 pathway in the recovery of skin following burns. J Invest Dermatol 126:468-76 (Pubitemid 43323185)
2. Chong BF, Mohan C (2009) Targeting the CXCR4/CXCL12 axis in systemic lupus erythematosus. Expert Opin Ther Targets 13:1147-53
3. Chow KY, Brotin E, Ben Khalifa Y et al. (2010) A pivotal role for CXCL12 signaling in HPVmediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome. Cell Host Microbe 8:523-33
4. Chu CY, Cha ST, Lin WC et al. (2009) Stromal cellderived factor-1alpha (SDF-1alpha/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-kappaB/interleukin-6 pathway. Carcinogenesis 30: 205-13
5. Di Meglio P, Nestle FO (2010) The role of IL-23 in the immunopathogenesis of psoriasis. F1000 Biol Rep; 2. pii: 40
6. Duda DG, Kozin SV, Kirkpatrick ND et al. (2011) CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies? Clin Cancer Res 17:2074-80
7. Florin L, Maas-Szabowski N,Werner S et al. (2005) Increased keratinocyte proliferation by JUNdependent expression of PTN and SDF-1 in fibroblasts. J Cell Sci 118:1981-9 (Pubitemid 40723841)
8. Gallagher KA, Liu ZJ, Xiao M et al. (2007) Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J Clin Invest 117:1249-59 (Pubitemid 46718413)
9. Henderson PW, Singh SP, Krijgh DD et al. (2011) Stromal-derived factor-1 delivered via hydrogel drug-delivery vehicle accelerates wound healing in vivo. Wound Repair Regen 19: 420-5
10. Hu C, Yong X, Li C et al. (2013) CXCL12/CXCR4 axis promotes mesenchymal stem cell mobilization to burn wounds and contributes to wound repair. J Surg Res 183:420-5
11. Kalatskaya I, Berchiche YA, Gravel S et al. (2009) AMD3100 is a CXCR7 ligand with allosteric agonist properties. Mol Pharmacol 75:1240-7
12. Maksym RB, Tarnowski M, Grymula K et al. (2009) The role of stromal-derived factor-1-CXCR7 axis in development and cancer. Eur J Pharmacol 625:31-40
13. Nishimura Y, Ii M, Qin G et al. (2012) CXCR4 antagonist AMD3100 accelerates impaired wound healing in diabetic mice. J Invest Dermatol 132:711-20
14. Petit I, Szyper-Kravitz M, Nagler A et al. (2002) GCSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 3:687-94 (Pubitemid 34752479)
15. Rabbany SY, Pastore J, Yamamoto M et al. (2010) Continuous delivery of stromal cellderived factor-1 from alginate scaffolds accelerates wound healing. Cell Transplant 19:399-408
16. Sarkar A, Tatlidede S, Scherer SS et al. (2011) Combination of stromal cell-derived factor-1 and collagen-glycosaminoglycan scaffold delays contraction and accelerates reepithelialization of dermal wounds in wild-type mice. Wound Repair Regen 19:71-9
17. Takekoshi T, Wu X, Mitsui H et al. (2013) CXCR4 negatively regulates keratinocyte proliferation in IL-23-mediated psoriasiform dermatitis. J Invest Dermatol 133:2530-7
18. Toksoy A, Muller V, Gillitzer R et al. (2007) Biphasic expression of stromal cell-derived factor-1 during human wound healing. Br J Dermatol 157:1148-54 (Pubitemid 350115705)
19. Xu X., Zhu F., Zhang M. et al. (2013) Stromal cell-derived factor-1 enhances wound healing through recruiting bone marrowderived mesenchymal stem cells to the wound area and promoting neovascularization. Cells Tissues Organs 197: 103-13